P. Carver

发表

C H Nightingale, C. Nightingale, P. Carver, 1987, Clinics in laboratory medicine.

Use of azoles for systemic antifungal therapy.

C. Kauffman, P. Carver, Carol A. Kauffman, 1997, Advances in pharmacology.

Dosing and monitoring of trace elements in long-term home parenteral nutrition patients.

K. Welch, P. Carver, Imad F. Btaiche, 2011, JPEN. Journal of parenteral and enteral nutrition.

Impact of mecA Gene Testing and Intervention by Infectious Disease Clinical Pharmacists on Time to Optimal Antimicrobial Therapy for Staphylococcus aureus Bacteremia at a University Hospital

Shu-Wen Lin, D. Newton, P. Carver, 2008, Journal of Clinical Microbiology.

Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents

P. Carver, L. Benitez, 2019, Drugs.

The Evolving Role of Antifungal Susceptibility Testing

P. Carver, G. Eschenauer, Gregory A. Eschenauer, 2013, Pharmacotherapy.

Meal Composition Effects on the Oral Bioavailability of Indinavir in HIV-Infected Patients

D. Fleisher, S. Zhou, D. Kaul, 1999, Pharmaceutical Research.

Candida glabrata fungemia: experience in a tertiary care center.

C. Kauffman, P. Carver, A. Malani, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Role of divalent metals in infectious disease susceptibility and outcome.

G. Weiss, P. Carver, Günter Weiss, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Metal ions and infectious diseases. An overview from the clinic.

P. Carver, 2013, Metal ions in life sciences.

Role of Unit-Specific Combination Antibiograms for Improving the Selection of Appropriate Empiric Therapy for Gram-Negative Pneumonia

D. Newton, P. Carver, J. Pogue, 2011, Infection Control & Hospital Epidemiology.

In vivo interaction of ketoconazole and sucralfate in healthy volunteers

R. Berardi, M. J. Knapp, S. Bradley, 1994, Antimicrobial Agents and Chemotherapy.

Impact of an Antimicrobial Stewardship Program Comprehensive Care Bundle on Management of Candidemia

T. Gandhi, L. Washer, J. Nagel, 2013, Pharmacotherapy.

Dalbavancin: A New Option for the Treatment of Gram-Positive Infections

Shu-Wen Lin, P. Carver, D. Depestel, 2006, The Annals of pharmacotherapy.

Alterations in gastric acidity in patients infected with human immunodeficiency virus.

L. Welage, S. Revankar, C. Kauffman, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.

O. Manuel, J. Pascual, E. Cordero, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Antifungal Prophylaxis in Lung Transplant Recipients

P. Carver, T. Patel, G. Eschenauer, 2016, Transplantation.

Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

J. Turnidge, S. Lockhart, T. Peláez, 2015, Antimicrobial Agents and Chemotherapy.

Antifungal Agents in the 1990s

C. Kauffman, P. Carver, 1997, Drugs.

Risk Factors for Systemic Vancomycin Exposure Following Administration of Oral Vancomycin for the Treatment of Clostridium difficile Infection

Rachel F. Eyler, Alexander L. Fohl, P. Carver, 2015, Pharmacotherapy.

Primary Antifungal Prophylaxis in Adult Hematopoietic Stem Cell Transplant Recipients: Current Therapeutic Concepts

P. Carver, D. Depestel, D. Mccoy, 2009, Pharmacotherapy.

Ceftaroline Fosamil: A Novel Broad-Spectrum Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus

P. Carver, D. Depestel, M. Jorgenson, 2011, The Annals of pharmacotherapy.

Peritoneal Dialysis Fluid Concentrations of Linezolid in the Treatment of Vancomycin‐Resistant Enterococcus faecium Peritonitis

C. Peloquin, P. Carver, D. Depestel, 2003, Pharmacotherapy.

Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case–Control Study

M. Nucci, O. Manuel, J. Pascual, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Comparison of echinocandin antifungals

P. Carver, Gregory Eschenauer, Daryl D DePestel, 2007, Therapeutics and clinical risk management.

Are In Vitro Susceptibilities to Azole Antifungals Predictive of Clinical Outcome in the Treatment of Candidemia?

P. Carver, T. Patel, G. Eschenauer, 2018, Journal of Clinical Microbiology.

Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study.

S. Schneeweiss, T. Auton, M. Saul, 2016, The Journal of antimicrobial chemotherapy.

In vitro analysis of the interaction between sucralfate and ketoconazole

V. Pecoraro, J. Hoeschele, P. Carver, 1994, Antimicrobial Agents and Chemotherapy.

Isavuconazole

P. Carver, N. Pettit, 2015, The Annals of pharmacotherapy.

Magnitude and Duration of Elevated Gastric pH in Patients Infected with Human Immunodeficiency Virus After Administration of Chewable, Dispersible, Buffered Didanosine Tablets

S. Cinti, C. Kauffman, P. Carver, 2004, Pharmacotherapy.

Modification of gastric pH with oral glutamic acid hydrochloride.

R. Berardi, M. J. Knapp, J. Dressman, 1991, Clinical pharmacy.

Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select Immunosuppressants

P. Carver, D. Depestel, A. Saad, 2006, Pharmacotherapy.

Update on Echinocandin Antifungals

C. Kauffman, P. Carver, Carol Kauffman1, 2008, Seminars in respiratory and critical care medicine.

Intra-Abdominal Infections

P. Carver, 1992 .

Clinically relevant drug interactions and adverse effects of antimicrobial agents

P. Carver, 1991 .

Antifungal agents in the 1990s. Current status and future developments.

C. Kauffman, P. Carver, 1997, Drugs.

Evolving role of early antifungals in the adult intensive care unit

P. Carver, G. Eschenauer, S. Lam, 2009, Critical care medicine.

Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.

S. Schneeweiss, M. Saul, Melissa D. Johnson, 2019, The Journal of antimicrobial chemotherapy.

Multi-center evaluation of antifungal time-kill methods

M. Klepser, M. Pfaller, D. Nicolau, 2001 .

Pharmacokinetics and pharmacodynamics of total and unbound cefoxitin and cefotetan in healthy volunteers.

R. Quintiliani, C. Nightingale, P. Carver, 1989, The Journal of antimicrobial chemotherapy.

Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study

O. Manuel, J. Pascual, E. Cordero, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Harnessing the power of fungal siderophores for the imaging and treatment of human diseases

A. Shanzer, P. Carver, E. Gumienna-Kontecka, 2016 .

Steady‐state pharmacokinetics of delavirdine in HIV‐positive patients: Effect on erythromycin breath test

D. E. Smith, G. Amidon, P. Watkins, 1997, Clinical pharmacology and therapeutics.

Survival in Patients with Candida glabrata Bloodstream Infection Is Associated with Fluconazole Dose

Shu-Wen Lin, P. Carver, M. Pai, 2018, Antimicrobial Agents and Chemotherapy.

Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates

K. Hanson, S. Shoham, A. Morris, 2014, Antimicrobial Agents and Chemotherapy.

Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study.

Shu-Wen Lin, Yee-Chun Chen, C. Clancy, 2013, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers

R. Quintiliani, C. Nightingale, P. Carver, 1989, Antimicrobial Agents and Chemotherapy.

HIV Protease Inhibitors: Advances in Therapy and Adverse Reactions, Including Metabolic Complications

S. Cinti, D. Kaul, P. Carver, 1999, Pharmacotherapy.

Antibacterial activity of sucralfate versus aluminum chloride in simulated gastric fluid

L. Welage, P. Carver, K. Welch, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Antifungal prophylaxis in liver transplant recipients

P. Carver, G. Eschenauer, S. Lam, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Risk Factors for Arthralgias or Myalgias Associated with Quinupristin‐Dalfopristin Therapy

C. Kauffman, P. Carver, H. Vandenbussche, 2003, Pharmacotherapy.

Concurrent Administration of Sirolimus and Voriconazole: A Pilot Study Assessing Safety and Approaches to Appropriate Management

P. Carver, D. Depestel, D. Surowiec, 2008, Pharmacotherapy.

The Effect of Ciprofloxacin on the Pharmacokinetic and ECG Parameters of Quinidine

F. Morady, T. Annesley, P. Carver, 1990, Journal of clinical pharmacology.

Lack of Interaction Between the Peptidomimetic Substrates Captopril and Cephradine

G. Amidon, C. Ramachandran, L. Welage, 2009, Journal of clinical pharmacology.

The Battle for Iron between Humans and Microbes.

P. Carver, 2017, Current medicinal chemistry.